SYSCHEM (INDIA)
Back to Balance Sheet
|
SYSCHEM (INDIA) Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹50 Cr | ₹1.12 Cr | ₹1.44 Cr | ₹0.73 Cr | ₹0.75 Cr |
What is the latest Contingent Liabilities ratio of SYSCHEM (INDIA) ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹50 Cr |
| Mar2024 | ₹1.12 Cr |
| Mar2023 | ₹1.44 Cr |
| Mar2022 | ₹0.73 Cr |
| Mar2021 | ₹0.75 Cr |
How is Contingent Liabilities of SYSCHEM (INDIA) Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹50 Cr | 4,385.17 | |
| Mar2024 | ₹1.12 Cr | -22.29 | |
| Mar2023 | ₹1.44 Cr | 98.62 | |
| Mar2022 | ₹0.73 Cr | -3.07 | |
| Mar2021 | ₹0.75 Cr | - | |
Compare Contingent Liabilities of peers of SYSCHEM (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYSCHEM (INDIA) | ₹235.8 Cr | -5.9% | -8.7% | 20.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,075.0 Cr | 0.4% | 10.8% | 10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,486.0 Cr | 0.7% | 9.5% | 16.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,124.0 Cr | -2.5% | 6% | 36.2% | Stock Analytics | |
| CIPLA | ₹115,641.0 Cr | 9.7% | 16.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,589.0 Cr | 4.5% | 9.7% | 9% | Stock Analytics | |
SYSCHEM (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYSCHEM (INDIA) | -5.9% |
-8.7% |
20.2% |
| SENSEX | -2.7% |
-2.1% |
-5.3% |
You may also like the below Video Courses